Finanzwire Finanzwire
Basculer en Français
10104 Companies
206997 Keywords
137125 Articles
109700 Press releases
Headlines Articles Press releases Protenus, Inc. Remove
  1. Home
  2. Companies
  3. Protenus, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 02/07/2024 at 15:00, 2 years 1 month ago

    Protenus is Awarded Top-Performing Solutions Vendor in Two Segments for Second Consecutive Year Based on 2024 Best in KLAS Report

    Protenus, a healthcare compliance analytics platform, achieves highest score for patient privacy monitoring and drug diversion surveillance solutions for the second year in a row, as reported by 2024 Best in KLAS: Software & Services. Protenus' AI-driven solutions help healthcare organizations nationwide to proactively identify and prevent privacy data breaches and drug diversion, reducing manual tasks and focusing on better risk-reduction outcomes
    Protenus Healthcare Compliance Analytics Patient Privacy Monitoring Drug Diversion Surveillance Best In KLAS
    Logo of Protenus, Inc.
  • PRESS RELEASE

    published on 10/26/2023 at 14:00, 2 years 5 months ago

    Protenus Granted Fifth New Patent for Drug Diversion Surveillance Technology

    Logo of Protenus, Inc.
  • PRESS RELEASE

    published on 06/22/2023 at 18:00, 2 years 9 months ago

    New 2023 Diversion Digest From Protenus Spotlights the Prevalence of Drug Diversion in Healthcare

    Logo of Protenus, Inc.
  • PRESS RELEASE

    published on 03/08/2023 at 18:00, 3 years ago

    Protenus Earns Fourth Great Place to Work Certification

    Logo of Protenus, Inc.
Previous page
1 2
Accesswire
  • Published on 03/27/2026 at 12:00, 26 minutes ago

    Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development

  • Published on 03/27/2026 at 12:00, 26 minutes ago

    Athena Gold Announces Share Consolidation

  • Published on 03/27/2026 at 11:00, 1 hour 26 minutes ago

    RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation

  • Published on 03/27/2026 at 09:30, 2 hours 56 minutes ago

    Amap Street Stars Launches Macao Authentic Delicacies Ranking to Drive Cultural-Tourism Innovation in the Greater Bay Area

  • Published on 03/27/2026 at 08:05, 4 hours 21 minutes ago

    Battery X Metals Announces Corporate Awareness Engagements

View all ACCESSWIRE
EQS Group
  • Published on 03/27/2026 at 11:45, 41 minutes ago

    Second National Showcase of Outstanding Works from China’s Rare Operatic Genres Held

  • Published on 03/27/2026 at 11:40, 46 minutes ago

    Disposal of shares in Pension Insurance Corporation Group Limited

  • Published on 03/27/2026 at 11:19, 1 hour 6 minutes ago

    The Payments Group Holding advances strategic initiatives successfully

  • Published on 03/27/2026 at 10:45, 1 hour 40 minutes ago

    Athora Group completes acquisition of Pension Insurance Corporation Group and announces plans to relocate headquarters to the UK

  • Published on 03/27/2026 at 10:40, 1 hour 45 minutes ago

    Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026

View all EQS
Les Echos
  • Published on 03/26/2026 at 18:17, 18 hours 9 minutes ago

    Eiffage strengthens its position in Getlink capital

  • Published on 03/26/2026 at 17:45, 18 hours 41 minutes ago

    Cegedim: profitability continues to improve

  • Published on 03/26/2026 at 08:57, 1 day 3 hours ago

    Edenred statement

  • Published on 03/26/2026 at 07:30, 1 day 4 hours ago

    BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY

  • Published on 03/25/2026 at 18:53, 1 day 17 hours ago

    LNA SANTE : 2025 Annual Results

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy